No Data
No Data
No Data
No Data
No Data
Sage Growth Partners Announces Marketing Partnership With Cognition Corporation
Baltimore-based healthcare growth strategy and marketing firm to support strategic marketing, thought leadership, and lead acquisition services BALTIMORE, April 30, 2024 /PRNewswire/ -- Sage Growth
PR NewswireApr 30 08:27 ET
Express News | Cognition Therapeutics Completes Enrollment In Phase 2 SHIMMER Study Of CT1812 In Mild-To-Moderate Dementia With Lewy Bodies, Top-line Results Are Expected In 2H Of 2024 After The Last Participants Have Completed Six Months Of Treatment
BenzingaApr 29 07:32 ET
Express News | Cognition Therapeutics Inc: Top-Line Results Are Expected in Second Half of 2024 After Last Participants Have Completed Six Months of Treatment
ReutersApr 29 07:31 ET
Express News | Cognition Therapeutics Completes Enrollment in Phase 2 Shimmer Study of Ct1812 in Mild-to-Moderate Dementia With Lewy Bodies
ReutersApr 29 07:31 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to
BenzingaApr 22 16:31 ET
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
PURCHASE, N.Y., April 22, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, provided
GlobeNewswireApr 22 07:30 ET
No Data
No Data
Jaguar8 : This is one of my fave and you know why
TrytosaveabitOP Jaguar8: Yup yup! I sure do! Im pretty keen on it myself! Hehehe